Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Whole Pelvic Hypofractionated Radiotherapy for the Treatment of Non-Metastatic Cervical and Endometrial Cancer, RT-PACE Trial

Trial Status: active

This phase I/II trial finds out the best dose, possible benefits, and side effects of whole pelvic hypofractionated radiotherapy for the treatment of non-metastatic cervical and endometrial cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.